COSCIENS Biopharma GAAP EPS of -$0.75, revenue of $2.7M
Source: SeekingAlpha
2025-08-15 03:06:27 ET
More on COSCIENS Biopharma Inc.
Read the full article on Seeking Alpha
For further details see:
COSCIENS Biopharma GAAP EPS of -$0.75, revenue of $2.7M
COSCIENS Biopharma Inc.
NASDAQ: CSCI
CSCI Trading
-12.01% G/L:
$2.6749 Last:
47,221 Volume:
$2.96 Open:
CSCI Latest News
December 01, 2025 05:05:00 pm
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
November 11, 2025 05:15:00 pm
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
August 14, 2025 05:20:00 pm
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
CSCI Stock Data
$6,853,789
2,920,878
2%
5
N/A
Biotechnology & Life Sciences
Healthcare
CA
Toronto
